R
Rapport Therapeutics, Inc. (RAPP)
NGM – Real vaqt narxi. Valyuta: USD
27.84
-1.16 (-4.00%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
28.45
+0.61 (2.19%)
Bozordan keyin: Mar 27, 2026, 6:42 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
NGM – Real vaqt narxi. Valyuta: USD
27.84
-1.16 (-4.00%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
28.45
+0.61 (2.19%)
Bozordan keyin: Mar 27, 2026, 6:42 PM EDT
This stock has a consensus price target of $44.78 based on the ratings of 10 analysts. The high is $80.00 and the low is $28.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 28 | $ 44.78 | $ 80 |
| O’zgarish | 0.57% | 60.85% | 187.36% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-03-11 | 90.37% | BTIG | $47 → $53 | Maintains | Buy |
| 2026-03-11 | 65.23% | Wells Fargo | $43 → $46 | Maintains | Overweight |
| 2026-02-02 | 54.45% | Wells Fargo | $43 | Initiates Coverage On | Overweight |
| 2025-12-09 | 43.68% | HC Wainwright & Co. | $34 → $40 | Maintains | Buy |
| 2025-12-08 | 68.82% | BTIG | $47 → $47 | Reiterates | Buy |